mhurhangee/ep-ind-claims huggingface dataset:
A feedback-based active noise reduction earphone, comprising: a speaker configured to generate an acoustic signal in response to a speaker input signal; a plurality of feedback microphones (66A,66B) each fixed in location, within a cavity of the earphone, relative to the speaker and to each of the other feedback microphones, each of the feedback microphones configured to generate a feedback microphone signal in response to an acoustic noise signal received at the feedback microphone; and a feedback system in communication with the speaker and the plurality of feedback microphones, the feedback system combining the feedback microphone signals into a single feedback error signal and generating the speaker input signal, wherein the speaker input signal comprises an inverse noise signal generated in response to the feedback error signal to generate an inverse acoustic noise signal at the speaker that substantially cancels the acoustic noise signal at a predetermined location relative to the speaker and the feedback microphones, characterized in that one of the feedback microphones is disposed at a location proximate to the speaker and another one of the feedback microphones is disposed at a location remote to the speaker. a speaker configured to generate an acoustic signal in response to a speaker input signal; a plurality of feedback microphones (66A,66B) each fixed in location, within a cavity of the earphone, relative to the speaker and to each of the other feedback microphones, each of the feedback microphones configured to generate a feedback microphone signal in response to an acoustic noise signal received at the feedback microphone; and a feedback system in communication with the speaker and the plurality of feedback microphones, the feedback system combining the feedback microphone signals into a single feedback error signal and generating the speaker input signal, wherein the speaker input signal comprises an inverse noise signal generated in response to the feedback error signal to generate an inverse acoustic noise signal at the speaker that substantially cancels the acoustic noise signal at a predetermined location relative to the speaker and the feedback microphones, characterized in that one of the feedback microphones is disposed at a location proximate to the speaker and another one of the feedback microphones is disposed at a location remote to the speaker.
A phosphorus compound represented by general formula: wherein R 1 and R 2 each independently represent a hydrogen atom, a linear, branched or cyclic alkyl group, a linear, branched or cyclic alkenyl group which may have a substituent(s), an aryl group which may have a substituent(s), a heteroaryl group which may have a substituent(s), an aralkyl group which may have a substituent(s), an alkoxy group which may have a substituent(s), or a halogeno group; R 3 represents a linear, branched or cyclic alkyl group, an aryl group which may have a substituent(s), or an aralkyl group which may have a substituent (s); R 4, R 5, R 6, R 7, R 8, R 9, and R 10 each independently represent a hydrogen atom, a linear, branched or cyclic alkyl group, a linear, branched or cyclic alkenyl group which may have a substituent(s), an aryl group which may have a substituent(s), or an aralkyl group which may have a substituent(s); N represents a nitrogen atom; P represents a phosphorus atom; Y represents lone pair electrons, an oxo group, or a thioxo group; Z represents an oxy group or a thioxy group; R 1 and R 2 may be bonded to each other to form a ring which contains P and may have a substituent (s); and each of the pairs of R 4 and R 5, R 5 and R 6, R 7 and R 8, R 8 and R 9, and R 9 and R 10 may be bonded to each other to form an unsaturated hydrocarbon ring which is fused with the benzene ring or the pyrrole ring and may have a substituent(s).
A backrest assembly for a vehicle seat comprising a tubular backrest framework comprising a tube, and at least one fixed support, said backrest framework being mounted so as to pivot relative to said at least one fixed support by means of a gusset welded to the tube and a hinge pin articulating said fixed support relative to the gusset, the gusset being a sheet metal comprising: - a first part in contact with the tube, fixed to the tube, on a first side of the tube, by a first weld, - a second part in contact with the tube and fixed to the tube, on a second side of the tube, by a second weld, the tube being received in a housing of the gusset, defined between the first part and the second part, the first part and the second part being offset from each other, transversely to the tube, along a dimension d of the housing, characterised in that the first part and the second part are offset from each other along the length of the tube. - a first part in contact with the tube, fixed to the tube, on a first side of the tube, by a first weld, - a second part in contact with the tube and fixed to the tube, on a second side of the tube, by a second weld, the tube being received in a housing of the gusset, defined between the first part and the second part, the first part and the second part being offset from each other, transversely to the tube, along a dimension d of the housing, characterised in that the first part and the second part are offset from each other along the length of the tube.
An injection sensing device or ISD for use with a medication delivery device, comprising: a thermal sensor configured to be applied to the skin of a patient and proximal to an injection site and to sense a change in temperature of the patient at the injection site and output corresponding sensor data; a processing device configured to receive the sensor data from the sensor and perform a designated operation when the processing device determines from the sensor data that the patient's temperature sensed at the injection site has changed by a designated amount relative to administration of an injection; and an indicator; characterized in that the processing device is configured to perform the designated operation by operating the indicator to indicate to the patient that medication delivery via the administration of the injection is complete in response to the processing device determining that the sensor data indicates that the patient's temperature sensed at the injection site began decreasing upon initiation of the injection and thereafter increasing to at least a designated amount in relation to the administration of the injection. a thermal sensor configured to be applied to the skin of a patient and proximal to an injection site and to sense a change in temperature of the patient at the injection site and output corresponding sensor data; a processing device configured to receive the sensor data from the sensor and perform a designated operation when the processing device determines from the sensor data that the patient's temperature sensed at the injection site has changed by a designated amount relative to administration of an injection; and an indicator; characterized in that the processing device is configured to perform the designated operation by operating the indicator to indicate to the patient that medication delivery via the administration of the injection is complete in response to the processing device determining that the sensor data indicates that the patient's temperature sensed at the injection site began decreasing upon initiation of the injection and thereafter increasing to at least a designated amount in relation to the administration of the injection.
An industrial robot, in particular an articulated robot, comprising: at least one member (12, 20, 70) which is rotatably supported on another component of the robot via a rotary joint; a sensor device for detecting the relative rotational movement between the member (12, 20, 70) and the other component, wherein the sensor device comprises a sensor (50, 50', 50") and an indicator tape, and wherein the indicator tape is arranged on the member (12, 20, 70) and the sensor (50, 50', 50") is arranged on the other component, or vice versa; and wherein the sensor (50, 50', 50") is configured to detect the indicators provided on the indicator tape to determine the relative rotational movement between the member and the component, wherein the robot further comprises at least one cover device (30; 40; 60) covering the indicator tape and at least the head of the sensor (50; 50'; 50") to protect the sensor device from dirt, characterized in that the cover device (30; 40; 60) is provided with brushes formed to prevent dirt from entering a gap between the cover device and a surface of the robot covered by the cover device and/or to strip dirt from the indicator tape. at least one member (12, 20, 70) which is rotatably supported on another component of the robot via a rotary joint; a sensor device for detecting the relative rotational movement between the member (12, 20, 70) and the other component, wherein the sensor device comprises a sensor (50, 50', 50") and an indicator tape, and wherein the indicator tape is arranged on the member (12, 20, 70) and the sensor (50, 50', 50") is arranged on the other component, or vice versa; and wherein the sensor (50, 50', 50") is configured to detect the indicators provided on the indicator tape to determine the relative rotational movement between the member and the component, wherein the robot further comprises at least one cover device (30; 40; 60) covering the indicator tape and at least the head of the sensor (50; 50'; 50") to protect the sensor device from dirt, characterized in that the cover device (30; 40; 60) is provided with brushes formed to prevent dirt from entering a gap between the cover device and a surface of the robot covered by the cover device and/or to strip dirt from the indicator tape.
A silane of formula, Si(R 1) m (R 2) n (R 3) 4-(m+n) wherein each R 1 independently represents: a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group; a substituted or unsubstituted cycloaliphatic functional group or aryl functional group; a substituted or unsubstituted heteroalicyclic functional group or heteroaryl functional group; each R 2 independently represents a functional group of the general formula: wherein each R 4 independently represents: hydrogen; or a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group; R 5 represents: a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group; a functional group of the general formula: -OR 5-2 wherein R 5-2 represents: a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group; or a functional group of the general formula: wherein R 5-3 represents: a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group; each R 3 independently represents a functional group of general formula: wherein each R 6 independently represents: hydrogen or a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group; R 7 represents: hydrogen, a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group; a substituted or unsubstituted cycloaliphatic functional group or aryl functional group, R 8, or a -(CH 2) q -COOR 9 functional group, wherein q is an integer from 2 to 10, in particular 2, and R 9 represents a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group or a substituted or unsubstituted cycloaliphatic functional group or aryl functional group; R 8 represents a functional group of general formula: -R 10 -SiR 11 o (OR 12) 3-o wherein R 10 represents: an alkylene functional group optionally interrupted by a heteroatom; each R 11 independently represents: a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group; each R 12 independently represents: a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group, an acyl functional group; or a functional group of formula: wherein each R 13 independently represents: hydrogen; or a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group; R 14 represents: a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group; and o independently represents 0, 1, or 2, and m independently represents 0 or 1 and n independently represents 0, 1, 2 or 3, wherein the sum n + m is a maximum of 3. a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group; a substituted or unsubstituted cycloaliphatic functional group or aryl functional group; a substituted or unsubstituted heteroalicyclic functional group or heteroaryl functional group; hydrogen; or a substituted or unsubstituted alkyl, alkenyl or alkynyl functional group;
A rigid-flex circuit board having a flying-tail structure, comprising a first rigid region, at least two flexible regions, and a plurality of second parallel planar rigid regions with a number equal to the number of flexible regions, characterized in that the one end of the first rigid region is coupled to one end of each of the at least two flexible regions respectively, the other end of each of the at least two flexible regions is coupled to one of the plurality of second parallel planar rigid regions respectively, and polyetherimide covering films are attached to solder-resist areas of adjacent end surfaces of the respective second parallel planar rigid regions. a first rigid region, at least two flexible regions, and a plurality of second parallel planar rigid regions with a number equal to the number of flexible regions, characterized in that the one end of the first rigid region is coupled to one end of each of the at least two flexible regions respectively, the other end of each of the at least two flexible regions is coupled to one of the plurality of second parallel planar rigid regions respectively, and polyetherimide covering films are attached to solder-resist areas of adjacent end surfaces of the respective second parallel planar rigid regions.
Method for producing a pigment paste by mixing at least one pigment, consisting of solid particles, with a grind resin in the presence of water and/or an organic liquid, characterized in that the grind resin comprises a dispersion of core-shell particles in an epoxide prepolymer which is liquid at 20°C, or consists of such a dispersion, and the core-shell particles have a silicone core and a polymer shell.
A multilayer body for use in a laser marking label, said multilayer body comprising: a first layer that allows laser light to pass through; a second layer that develops a color with the laser light; and a third layer that has adhesiveness, the first layer, the second layer, and the third layer being stacked in this order, the second layer consisting of a resin composition containing an acrylic-based copolymer, an isocyanate-based crosslinking agent, a color development pigment, and a white pigment, the isocyanate-based crosslinking agent being selected from (i) an aromatic-aliphatic isocyanate-based crosslinking agent or (ii) a mixture of an aliphatic or alicyclic isocyanate-based crosslinking agent and an aromatic isocyanate-based crosslinking agent, a contained amount of the isocyanate-based crosslinking agent being not less than 5 parts by mass and not more than 40 parts by mass with respect to 100 parts by mass of the acrylic-based copolymer, and the second layer being in contact with the first layer. a first layer that allows laser light to pass through; a second layer that develops a color with the laser light; and a third layer that has adhesiveness, the first layer, the second layer, and the third layer being stacked in this order, the second layer consisting of a resin composition containing an acrylic-based copolymer, an isocyanate-based crosslinking agent, a color development pigment, and a white pigment, the isocyanate-based crosslinking agent being selected from (i) an aromatic-aliphatic isocyanate-based crosslinking agent or (ii) a mixture of an aliphatic or alicyclic isocyanate-based crosslinking agent and an aromatic isocyanate-based crosslinking agent, a contained amount of the isocyanate-based crosslinking agent being not less than 5 parts by mass and not more than 40 parts by mass with respect to 100 parts by mass of the acrylic-based copolymer, and the second layer being in contact with the first layer.
An inspection method of an object by ultrasound transmission, wherein a scanning of said object by an ultrasound beam and measurement of the amplitude of the ultrasound beam transmitted via said object are carried out, said measurement comprising conversion of the ultrasound beam into an electrical signal, the application of an amplification gain to said signal and measurement of the amplitude of said signal, to deduce therefrom a mapping in which each point of a projection surface of said object according to the direction of exposure is associated to the amplitude of the ultrasound beam transmitted to said point via said object, the method comprising the steps consisting of: - carrying out said scanning and said amplitude measurement on a reference piece having a geometry identical to the object to be inspected, to deduce therefrom a mapping of said piece associating to each point of the scanning the transmitted amplitude at said point, the amplification gain applied for the amplitude measurement being a predetermined reference gain (G ref), - determining, at each point of the mapping of the reference piece, gain corrections to be made to the reference gain (G ref) at each of the corresponding points of the scanning to obtain a constant amplitude of the ultrasound beam (A c) transmitted via the reference piece for all the points of the mapping, - carrying out said scanning and said amplitude measurement on the object to be inspected, by applying to the different points of the scanning an amplification gain (G c) corresponding to the reference gain (G ref) corrected from the gain corrections previously determined. - carrying out said scanning and said amplitude measurement on a reference piece having a geometry identical to the object to be inspected, to deduce therefrom a mapping of said piece associating to each point of the scanning the transmitted amplitude at said point, the amplification gain applied for the amplitude measurement being a predetermined reference gain (G ref), - determining, at each point of the mapping of the reference piece, gain corrections to be made to the reference gain (G ref) at each of the corresponding points of the scanning to obtain a constant amplitude of the ultrasound beam (A c) transmitted via the reference piece for all the points of the mapping, - carrying out said scanning and said amplitude measurement on the object to be inspected, by applying to the different points of the scanning an amplification gain (G c) corresponding to the reference gain (G ref) corrected from the gain corrections previously determined.
A composition for use in treating a subject with symptoms of a stroke or acute myocardial infarction at a maximum rate of clot lysis and with minimal associated hemorrhagic side effects, the composition comprising: a first composition comprising less than 5 mg of tissue plasminogen activator (tPA), wherein the first composition is or is prepared to be administered to a subject in a dosage regime of a bolus comprising 2 to 4.5 mg of tPA; and a second composition comprising a pro-urokinase mutant (mproUK) comprising a substitution of histidine for lysine at amino acid position 300 (Lys300→His) of prourokinase, wherein the second composition is or is prepared to be administered to a subject by an intravenous infusion in a dosage regime of 60 to 120 mg/hour for 60 to 90 minutes following the administration of the first composition; wherein the subject is identified as potentially having had a stroke or AMI by observing one or more symptoms of a stroke or AMI without determining the cause of the stroke prior to administering the first composition; and wherein a maximum clot lysis rate is achieved with minimal associated hemorrhagic side effects. a first composition comprising less than 5 mg of tissue plasminogen activator (tPA), wherein the first composition is or is prepared to be administered to a subject in a dosage regime of a bolus comprising 2 to 4.5 mg of tPA; and a second composition comprising a pro-urokinase mutant (mproUK) comprising a substitution of histidine for lysine at amino acid position 300 (Lys300→His) of prourokinase, wherein the second composition is or is prepared to be administered to a subject by an intravenous infusion in a dosage regime of 60 to 120 mg/hour for 60 to 90 minutes following the administration of the first composition; wherein the subject is identified as potentially having had a stroke or AMI by observing one or more symptoms of a stroke or AMI without determining the cause of the stroke prior to administering the first composition; and wherein a maximum clot lysis rate is achieved with minimal associated hemorrhagic side effects.
Expression kit for a breast pump device for extracting breast milk from a human breast, the expression kit comprising a breast pump body having a first pressure chamber, a second pressure chamber, and a membrane portion separating the first and the second pressure chamber (21, 22) from each other, - wherein the first pressure chamber is configured for connection to a pressure unit for generating a pressure in the first pressure chamber, - wherein the second pressure chamber comprises a breast-receiving funnel, a milk outlet, and a milk path from the breast-receiving funnel to the milk outlet, - wherein the membrane portion is configured to form a barrier between the first and the second pressure chamber (21, 22) for preventing leakage of human breast milk from the second pressure chamber to the first pressure chamber, yet to allow for air exchange between the first and the second pressure chamber (21, 22), and - wherein the membrane portion is hydrophobic and characterized in that the membrane portion has the shape of a solid sheet having a continuous appearance and being provided with holes which are configured for rendering the sheet permeable to air and impermeable to liquid. - wherein the first pressure chamber is configured for connection to a pressure unit for generating a pressure in the first pressure chamber, - wherein the second pressure chamber comprises a breast-receiving funnel, a milk outlet, and a milk path from the breast-receiving funnel to the milk outlet, - wherein the membrane portion is configured to form a barrier between the first and the second pressure chamber (21, 22) for preventing leakage of human breast milk from the second pressure chamber to the first pressure chamber, yet to allow for air exchange between the first and the second pressure chamber (21, 22), and - wherein the membrane portion is hydrophobic and characterized in that the membrane portion has the shape of a solid sheet having